Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Alcoholism (mmu05034)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1700012L
04Rik
KLA  ATP  ATP+KLA
 NM_029588 RIKEN cDNA 1700012L04 gene (1700012L04Rik), mRNA [NM_029588] KLA .99 .98 .99 .98 .90 .94 .89
ATP 1.00 1.02 1.05 .97 .92 .97 .96
KLA/ATP .96 .95 .98 .91 .95 .92 1.00
1700014N
06Rik
KLA  ATP  ATP+KLA
 AK005982 adult male testis cDNA, RIKEN full-length enriched library, clone:1700014N06 product:HISTONE H2B, full insert sequence [AK005982] KLA .97 .96 1.05 1.06 1.01 1.00 1.00
ATP 1.01 1.03 1.03 .99 1.00 1.00 1.00
KLA/ATP .91 1.06 1.06 1.01 1.04 .96 .93
1700024P
04Rik
KLA  ATP  ATP+KLA
 BU938589 gb|AGENCOURT_10517723 NIH_MGC_169 Mus musculus cDNA clone IMAGE:6706749 5, mRNA sequence [BU938589] KLA .92 .86 .99 1.02 .96 .97 .99
ATP .95 .87 1.05 .99 .94 .97 .92
KLA/ATP .98 1.00 1.02 1.01 1.04 .88 .94
1700113O
17Rik
KLA  ATP  ATP+KLA
 NM_026627 RIKEN cDNA 1700113O17 gene (1700113O17Rik), mRNA [NM_026627] KLA .99 .99 .95 .96 1.01 .95 .98
ATP 1.06 1.24 1.21 1.11 .98 .97 .94
KLA/ATP .99 1.06 1.03 .94 .93 .94 .87
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adora2a
KLA  ATP  ATP+KLA
 NM_009630 adenosine A2a receptor (Adora2a), mRNA [NM_009630] KLA 9.23 9.88 9.08 9.21 9.36 7.45 8.23
ATP 1.09 1.01 1.36 2.05 4.26 8.29 1.91
KLA/ATP 9.17 11.00 9.06 9.28 10.88 11.46 9.73
Adora2b
KLA  ATP  ATP+KLA
 NM_007413 adenosine A2b receptor (Adora2b), mRNA [NM_007413] KLA 2.50 3.09 4.71 7.11 7.38 4.18 3.17
ATP .98 1.02 1.16 4.52 8.81 7.95 2.66
KLA/ATP 2.56 3.38 4.49 5.78 7.34 7.41 6.23
AK015962
KLA  ATP  ATP+KLA
 AK015962 adult male testis cDNA, RIKEN full-length enriched library, clone:4930534G10 product:unclassifiable, full insert sequence. [AK015962] KLA 1.72 1.61 1.62 1.79 1.30 1.73 .70
ATP .81 .87 1.67 1.60 1.11 1.18 .78
KLA/ATP 1.28 1.54 2.72 2.59 2.32 1.92 1.61
Araf
KLA  ATP  ATP+KLA
 NM_009703 v-raf murine sarcoma 3611 viral oncogene homolog (Araf), mRNA [NM_009703] KLA .87 .80 .89 .93 1.10 1.19 1.16
ATP 1.09 1.11 1.19 1.18 .78 .53 1.18
KLA/ATP 1.00 .95 .99 .93 .63 .55 1.27
Atf2
KLA  ATP  ATP+KLA
 AK047405 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930056P03 product:activating transcription factor 2, full insert sequence. [AK047405] KLA 1.01 1.00 1.02 1.04 1.03 1.03 1.00
ATP .99 1.00 .95 1.01 1.04 .98 1.03
KLA/ATP 1.07 1.00 .98 .99 1.00 1.03 .93
Atf2
KLA  ATP  ATP+KLA
 NM_001025093 activating transcription factor 2 (Atf2), transcript variant 1, mRNA [NM_001025093] KLA 1.35 1.30 1.32 1.31 1.37 1.09 1.20
ATP 1.15 1.17 .99 1.11 1.22 1.39 1.28
KLA/ATP 1.38 1.42 1.21 1.28 1.17 1.33 1.69
Atf4
KLA  ATP  ATP+KLA
 NM_009716 activating transcription factor 4 (Atf4), mRNA [NM_009716] KLA .91 1.06 1.13 1.31 1.92 2.59 3.01
ATP 1.05 1.14 1.34 2.88 4.84 2.36 2.56
KLA/ATP 1.14 1.08 1.17 2.40 3.72 3.54 3.62
Bdnf
KLA  ATP  ATP+KLA
 NM_007540 brain derived neurotrophic factor (Bdnf), transcript variant 1, mRNA [NM_007540] KLA 1.00 1.01 1.01 1.01 1.01 1.00 .99
ATP 1.00 1.00 1.00 1.01 .99 .99 1.01
KLA/ATP 1.00 1.01 1.01 1.02 1.03 1.03 .98
Braf
KLA  ATP  ATP+KLA
 NM_139294 Braf transforming gene (Braf), mRNA [NM_139294] KLA 1.52 1.57 1.55 1.33 1.83 1.52 1.60
ATP 1.08 1.17 1.02 1.37 .95 1.15 .95
KLA/ATP 1.64 1.69 1.39 1.51 1.04 1.31 1.26
Calm1
KLA  ATP  ATP+KLA
 NM_009790 calmodulin 1 (Calm1), mRNA [NM_009790] KLA 1.20 1.26 1.30 1.06 1.16 1.09 1.18
ATP 1.07 1.20 1.00 1.29 .99 .64 .58
KLA/ATP 1.31 1.31 .93 1.31 .97 .83 .59
Calm2
KLA  ATP  ATP+KLA
 NM_007589 calmodulin 2 (Calm2), mRNA [NM_007589] KLA .79 .81 .71 .67 .54 .45 .64
ATP .99 1.03 1.04 .93 .82 .52 .76
KLA/ATP .76 .78 .76 .77 .73 .47 .42
Calm3
KLA  ATP  ATP+KLA
 NM_007590 calmodulin 3 (Calm3), mRNA [NM_007590] KLA .95 .96 .93 1.03 1.05 1.08 1.00
ATP .93 .96 .99 .97 .93 .84 .72
KLA/ATP .89 .93 .90 .91 1.02 .98 .70
Calm4
KLA  ATP  ATP+KLA
 NM_020036 calmodulin 4 (Calm4), mRNA [NM_020036] KLA 1.02 .96 1.05 1.00 .99 1.00 1.01
ATP 1.10 1.05 1.03 1.01 .94 .98 .98
KLA/ATP .99 1.12 1.01 1.03 .98 1.07 1.02
Calm5
KLA  ATP  ATP+KLA
 NM_001008706 calmodulin 5 (Calm5), mRNA [NM_001008706] KLA 1.02 1.11 .99 .98 1.07 1.01 1.09
ATP 1.07 1.05 1.04 1.04 1.01 1.04 .99
KLA/ATP 1.00 1.00 .97 1.07 1.00 1.07 .98
Calml3
KLA  ATP  ATP+KLA
 NM_027416 calmodulin-like 3 (Calml3), mRNA [NM_027416] KLA 1.01 .95 1.05 .91 1.01 .98 .89
ATP .91 1.05 1.04 1.01 .93 1.07 .99
KLA/ATP 1.01 .96 .97 .96 .97 .92 .99
Camk4
KLA  ATP  ATP+KLA
 AK043457 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730097A20 product:CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE IV CATALYTIC CHAIN (EC 2.7.1.123) (CAM KINASE-GR) (CAMK IV) [CONTAINS: CALSPERMIN] homolog [Mus KLA .98 1.04 1.02 .93 1.03 1.07 1.07
ATP 1.01 .97 .97 1.10 1.00 .99 1.05
KLA/ATP 1.00 .96 1.02 .98 1.13 1.07 1.00
Camk4
KLA  ATP  ATP+KLA
 NM_009793 calcium/calmodulin-dependent protein kinase IV (Camk4), mRNA [NM_009793] KLA .96 1.02 1.01 1.02 1.03 1.07 1.08
ATP 1.01 1.03 1.07 1.08 .99 1.00 .99
KLA/ATP 1.01 .95 .98 1.08 1.12 1.02 1.03
Camkk1
KLA  ATP  ATP+KLA
 NM_018883 calcium/calmodulin-dependent protein kinase kinase 1, alpha (Camkk1), mRNA [NM_018883] KLA 1.32 1.27 1.41 1.73 1.91 1.60 1.89
ATP 1.03 1.05 1.11 1.09 1.70 2.29 1.27
KLA/ATP 1.21 1.21 1.31 1.31 3.34 3.82 2.44
Camkk2
KLA  ATP  ATP+KLA
 AK050846 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030025I01 product:unclassifiable, full insert sequence [AK050846] KLA 2.02 1.85 2.02 1.83 1.43 .64 .86
ATP 1.21 1.22 .90 .95 .80 .56 .47
KLA/ATP 2.19 2.23 1.27 1.40 .81 .52 .49
Camkk2
KLA  ATP  ATP+KLA
 NM_145358 calcium/calmodulin-dependent protein kinase kinase 2, beta (Camkk2), mRNA [NM_145358] KLA 2.12 1.87 1.66 2.02 1.36 .63 .68
ATP 1.11 1.00 .80 .78 .82 .74 .41
KLA/ATP 1.78 2.21 1.81 1.37 1.13 .58 .46
Creb1
KLA  ATP  ATP+KLA
 NM_009952 cAMP responsive element binding protein 1 (Creb1), transcript variant B, mRNA [NM_009952] KLA 1.42 1.33 1.16 .99 .83 .97 .92
ATP .92 .91 1.18 1.38 1.51 1.02 .75
KLA/ATP 1.34 1.31 1.49 1.37 1.71 1.05 .93
Creb3
KLA  ATP  ATP+KLA
 NM_013497 cAMP responsive element binding protein 3 (Creb3), mRNA [NM_013497] KLA 1.21 1.21 1.23 1.53 1.77 1.77 1.31
ATP 1.02 1.03 .99 1.05 .82 .83 1.48
KLA/ATP 1.15 1.18 1.20 1.26 1.13 1.15 1.86
Creb3l1
KLA  ATP  ATP+KLA
 NM_011957 cAMP responsive element binding protein 3-like 1 (Creb3l1), mRNA [NM_011957] KLA 1.18 1.17 1.53 1.28 1.22 1.11 1.23
ATP 1.01 1.09 .98 1.17 1.22 1.01 1.15
KLA/ATP 1.22 1.29 1.08 1.34 1.14 1.36 1.12
Creb3l2
KLA  ATP  ATP+KLA
 AK082964 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530025K05 product:unclassifiable, full insert sequence [AK082964] KLA .44 .38 .37 .40 .45 .42 .47
ATP .90 .78 1.22 .79 .54 .46 .44
KLA/ATP .41 .41 .49 .43 .50 .51 .23
Creb3l2
KLA  ATP  ATP+KLA
 NM_178661 cAMP responsive element binding protein 3-like 2 (Creb3l2), mRNA [NM_178661] KLA .98 .87 .76 .98 1.03 .87 1.12
ATP 1.20 1.18 1.50 1.35 .86 1.32 1.50
KLA/ATP .98 1.04 1.15 1.05 .79 1.27 1.25
Creb3l3
KLA  ATP  ATP+KLA
 NM_145365 cAMP responsive element binding protein 3-like 3 (Creb3l3), mRNA [NM_145365] KLA .66 .75 .65 .85 1.04 1.44 1.73
ATP 1.02 .98 .97 1.09 .85 .69 1.11
KLA/ATP .70 .66 .71 .83 .80 .85 1.05
Creb3l4
KLA  ATP  ATP+KLA
 NM_030080 cAMP responsive element binding protein 3-like 4 (Creb3l4), mRNA [NM_030080] KLA 1.55 1.42 1.51 1.73 1.76 2.54 1.38
ATP 1.07 .81 .89 1.08 .94 1.08 1.08
KLA/ATP 1.44 1.38 1.44 1.25 1.30 1.26 2.24
Creb5
KLA  ATP  ATP+KLA
 AK051306 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130032G03 product:unclassifiable, full insert sequence. [AK051306] KLA 2.18 2.13 2.42 1.97 1.57 1.94 1.98
ATP 1.11 1.09 1.47 1.74 1.36 1.44 1.62
KLA/ATP 2.55 2.77 3.02 3.15 2.51 2.52 2.61
Creb5
KLA  ATP  ATP+KLA
 NM_172728 cAMP responsive element binding protein 5 (Creb5), mRNA [NM_172728] KLA 3.70 3.60 2.84 2.39 1.92 2.81 1.84
ATP .92 .89 1.19 1.93 1.51 1.55 1.44
KLA/ATP 3.16 3.51 4.33 5.35 5.78 3.23 3.03
Crebl1
KLA  ATP  ATP+KLA
 NM_017406 cAMP responsive element binding protein-like 1 (Crebl1), mRNA [NM_017406] KLA 1.22 1.30 1.32 1.34 1.51 1.52 1.75
ATP 1.13 1.32 1.16 1.66 1.06 .93 1.54
KLA/ATP 1.37 1.25 1.21 1.74 1.04 1.01 2.07
Ddc
KLA  ATP  ATP+KLA
 NM_016672 dopa decarboxylase (Ddc), mRNA [NM_016672] KLA 1.27 1.28 1.34 1.33 1.34 1.21 1.05
ATP 1.02 .99 1.05 .98 1.02 1.02 1.14
KLA/ATP 1.24 1.22 1.28 1.25 1.12 1.20 1.35
Drd1a
KLA  ATP  ATP+KLA
 NM_010076 dopamine receptor D1A (Drd1a), mRNA [NM_010076] KLA .94 .99 1.02 .98 .98 .99 1.06
ATP 1.07 1.03 1.01 1.08 1.08 .96 1.04
KLA/ATP 1.04 1.00 1.01 1.06 1.08 1.06 1.09
Drd2
KLA  ATP  ATP+KLA
 NM_010077 dopamine receptor 2 (Drd2), mRNA [NM_010077] KLA 1.02 .98 1.03 1.09 1.07 .97 1.09
ATP 1.07 1.00 .98 1.11 1.03 1.01 1.03
KLA/ATP 1.13 1.12 1.09 1.08 1.02 1.01 1.11
Drd2
KLA  ATP  ATP+KLA
 X55674 gb|M.musculus mRNA for D2A dopamine receptor [X55674] KLA .95 1.00 1.06 .98 .97 1.02 1.02
ATP .97 .97 .99 .97 .99 .97 1.01
KLA/ATP .97 1.03 .91 .90 .95 .89 1.00
EG333452
KLA  ATP  ATP+KLA
 NM_001085517 predicted gene, EG333452 (EG333452), mRNA [NM_001085517] KLA .89 1.00 .93 .91 .92 1.01 .94
ATP 1.16 1.08 1.01 .98 .92 .97 .93
KLA/ATP .97 .96 .97 .95 .98 .98 .87
EG385328
KLA  ATP  ATP+KLA
 NM_001034100 predicted gene, EG385328 (EG385328), mRNA [NM_001034100] KLA .99 1.01 .92 .96 .93 .90 .96
ATP 1.07 1.02 1.04 1.04 .95 .90 .91
KLA/ATP .95 .88 .95 .83 .84 .88 .89
Fosb
KLA  ATP  ATP+KLA
 NM_008036 FBJ osteosarcoma oncogene B (Fosb), mRNA [NM_008036] KLA .99 .88 .61 1.01 .74 1.03 1.00
ATP 8.75 11.87 14.21 15.92 11.71 3.22 1.29
KLA/ATP 3.13 5.07 3.50 7.61 4.95 3.70 1.87
Gnai1
KLA  ATP  ATP+KLA
 NM_010305 guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] KLA .95 1.01 1.01 1.00 1.09 1.10 1.08
ATP 1.06 1.06 .99 1.15 1.02 .94 .99
KLA/ATP 1.02 1.04 .99 1.16 1.01 1.02 1.13
Gnai2
KLA  ATP  ATP+KLA
 NM_008138 guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] KLA .74 .79 .82 .74 .91 .97 1.10
ATP 1.07 1.16 .78 1.12 .78 .48 .82
KLA/ATP .91 .81 .53 .80 .60 .68 .87
Gnai3
KLA  ATP  ATP+KLA
 NM_010306 guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] KLA 1.23 1.24 1.14 1.06 .99 1.15 1.09
ATP .96 .93 .86 .64 1.34 2.02 1.35
KLA/ATP 1.20 1.24 .97 .76 1.21 1.62 1.17
Gnao1
KLA  ATP  ATP+KLA
 NM_001113384 guanine nucleotide binding protein, alpha O (Gnao1), transcript variant B, mRNA [NM_001113384] KLA .95 .98 1.03 1.00 1.02 1.02 .99
ATP .95 1.02 1.01 1.08 .99 .97 .95
KLA/ATP 1.05 1.04 1.10 .99 1.01 .98 1.03
Gnao1
KLA  ATP  ATP+KLA
 NM_010308 guanine nucleotide binding protein, alpha O (Gnao1), transcript variant A, mRNA [NM_010308] KLA .98 .96 1.00 .97 .96 .97 1.01
ATP 1.12 .99 1.05 .87 .97 1.02 1.01
KLA/ATP .93 1.00 .99 1.01 1.05 1.07 .98
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Gnb1
KLA  ATP  ATP+KLA
 NM_008142 guanine nucleotide binding protein (G protein), beta 1 (Gnb1), mRNA [NM_008142] KLA 1.11 1.18 1.22 1.19 1.29 1.32 1.76
ATP 1.02 1.09 .84 .99 .97 .89 1.22
KLA/ATP 1.20 1.25 .85 1.01 .86 .91 1.57
Gnb2
KLA  ATP  ATP+KLA
 NM_010312 guanine nucleotide binding protein (G protein), beta 2 (Gnb2), mRNA [NM_010312] KLA .94 .98 .94 1.08 1.23 1.32 1.16
ATP 1.04 .96 .59 .64 .59 .76 1.18
KLA/ATP 1.02 .84 .62 .64 .61 .89 1.36
Gnb3
KLA  ATP  ATP+KLA
 NM_013530 guanine nucleotide binding protein (G protein), beta 3 (Gnb3), mRNA [NM_013530] KLA .99 1.00 .98 1.03 .94 .99 .96
ATP 1.01 1.02 .97 .95 1.01 .97 .92
KLA/ATP .99 1.02 1.02 .98 .99 .85 .99
Gnb4
KLA  ATP  ATP+KLA
 AK165084 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330002E21 product:guanine nucleotide binding protein, beta 4, full insert sequence [AK165084] KLA 4.61 4.10 4.23 2.41 2.25 1.59 .93
ATP 1.21 1.17 1.04 .81 2.92 1.50 1.03
KLA/ATP 5.86 6.56 3.60 1.68 5.62 3.00 1.37
Gnb4
KLA  ATP  ATP+KLA
 NM_013531 guanine nucleotide binding protein (G protein), beta 4 (Gnb4), mRNA [NM_013531] KLA 8.41 8.09 10.57 9.44 6.06 2.97 .92
ATP 1.07 1.04 1.09 .87 1.48 2.10 1.18
KLA/ATP 8.14 8.93 9.12 7.69 5.03 5.11 2.37
Gnb5
KLA  ATP  ATP+KLA
 NM_010313 guanine nucleotide binding protein (G protein), beta 5 (Gnb5), transcript variant 1, mRNA [NM_010313] KLA .68 .75 .67 .66 .53 .50 .65
ATP 1.03 1.08 1.09 1.14 .72 .54 .77
KLA/ATP .73 .70 .71 .73 .61 .65 .58
Gng10
KLA  ATP  ATP+KLA
 NM_025277 guanine nucleotide binding protein (G protein), gamma 10 (Gng10), mRNA [NM_025277] KLA .95 .95 .86 .83 .70 .53 .43
ATP .93 1.03 1.17 1.21 .97 .60 .52
KLA/ATP .84 .91 .93 .99 .79 .47 .24
Gng11
KLA  ATP  ATP+KLA
 NM_025331 guanine nucleotide binding protein (G protein), gamma 11 (Gng11), mRNA [NM_025331] KLA 1.30 1.26 1.44 1.54 1.26 1.42 1.90
ATP .88 .78 1.26 1.14 .90 .64 1.60
KLA/ATP 1.11 1.18 1.81 1.55 1.81 1.75 3.05
Gng12
KLA  ATP  ATP+KLA
 NM_025278 guanine nucleotide binding protein (G protein), gamma 12 (Gng12), mRNA [NM_025278] KLA 2.21 2.23 2.48 2.62 2.47 2.28 1.68
ATP 1.02 1.02 1.09 1.10 1.20 1.32 1.01
KLA/ATP 2.10 2.17 2.38 2.40 1.91 1.60 1.77
Gng13
KLA  ATP  ATP+KLA
 NM_022422 guanine nucleotide binding protein (G protein), gamma 13 (Gng13), mRNA [NM_022422] KLA 1.04 1.04 .94 1.00 1.00 1.05 .96
ATP 1.07 1.05 1.02 .94 .98 1.03 1.01
KLA/ATP 1.01 .99 1.05 1.01 1.01 .98 1.02
Gng2
KLA  ATP  ATP+KLA
 NM_010315 guanine nucleotide binding protein (G protein), gamma 2 (Gng2), transcript variant 1, mRNA [NM_010315] KLA .79 .81 .81 .82 .67 .57 .75
ATP 1.02 1.01 1.13 1.35 1.48 1.01 1.31
KLA/ATP .79 .86 .97 1.05 1.29 1.00 .84
Gng3
KLA  ATP  ATP+KLA
 NM_010316 guanine nucleotide binding protein (G protein), gamma 3 (Gng3), mRNA [NM_010316] KLA 1.00 .98 1.02 .95 .99 1.00 1.06
ATP .98 1.05 .99 1.03 1.05 1.03 .97
KLA/ATP 1.01 1.00 1.07 1.01 1.04 1.04 1.05
Gng4
KLA  ATP  ATP+KLA
 NM_010317 guanine nucleotide binding protein (G protein), gamma 4 (Gng4), mRNA [NM_010317] KLA 1.27 1.26 1.47 1.30 1.15 1.13 .82
ATP 1.05 .97 1.07 1.62 3.97 3.46 1.24
KLA/ATP 1.35 1.32 1.37 1.35 1.64 2.18 1.56
Gng5
KLA  ATP  ATP+KLA
 NM_010318 guanine nucleotide binding protein (G protein), gamma 5 (Gng5), mRNA [NM_010318] KLA .94 .84 .80 1.12 .98 1.11 1.29
ATP 1.07 1.01 1.07 1.05 1.17 1.52 1.01
KLA/ATP .83 .94 1.27 1.17 1.19 1.35 1.36
Gng7
KLA  ATP  ATP+KLA
 NM_001038655 guanine nucleotide binding protein (G protein), gamma 7 (Gng7), transcript variant 1, mRNA [NM_001038655] KLA .92 .96 .87 .91 .83 .98 .98
ATP 1.04 1.06 .98 .95 .81 .77 .75
KLA/ATP .97 .95 .81 .91 .79 .77 .81
Gng8
KLA  ATP  ATP+KLA
 NM_010320 guanine nucleotide binding protein (G protein), gamma 8 (Gng8), mRNA [NM_010320] KLA .93 .93 .95 .96 .90 .88 1.09
ATP .95 .90 1.01 .92 1.04 1.01 1.05
KLA/ATP .97 1.03 .99 .90 1.10 .99 1.04
Gngt1
KLA  ATP  ATP+KLA
 NM_010314 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 (Gngt1), mRNA [NM_010314] KLA 1.06 .99 .95 .98 1.03 1.10 .98
ATP .96 1.02 1.03 1.03 .94 1.06 .95
KLA/ATP .98 1.03 1.04 1.04 1.01 1.03 1.01
Grb2
KLA  ATP  ATP+KLA
 NM_008163 growth factor receptor bound protein 2 (Grb2), mRNA [NM_008163] KLA .92 .88 .90 1.27 1.43 1.22 1.00
ATP 1.02 .83 .51 .42 .92 .70 .57
KLA/ATP .84 .77 .61 .56 1.56 1.49 .52
Grb2
KLA  ATP  ATP+KLA
 U07617 Grb2 adaptor protein (grb2) mRNA, complete cds. [U07617] KLA .83 .80 .95 1.13 1.38 1.36 1.06
ATP .84 .74 .51 .41 .82 .74 .59
KLA/ATP .77 .70 .57 .54 1.49 1.39 .53
Grin1
KLA  ATP  ATP+KLA
 NM_008169 glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1), mRNA [NM_008169] KLA .90 .97 .91 .98 .93 .94 1.01
ATP 1.04 1.04 1.02 1.08 .96 .91 .93
KLA/ATP .90 .99 .95 .95 .94 .88 .89
Grin2a
KLA  ATP  ATP+KLA
 NM_008170 glutamate receptor, ionotropic, NMDA2A (epsilon 1) (Grin2a), mRNA [NM_008170] KLA 1.00 1.08 1.00 1.03 1.09 1.02 1.04
ATP .96 .94 1.00 .98 1.03 .97 1.01
KLA/ATP .95 1.02 1.03 .95 .99 .99 .95
Grin2b
KLA  ATP  ATP+KLA
 NM_008171 glutamate receptor, ionotropic, NMDA2B (epsilon 2) (Grin2b), mRNA [NM_008171] KLA 1.03 1.02 1.10 1.09 1.02 1.03 1.08
ATP 1.15 1.07 1.05 1.07 1.08 1.04 1.02
KLA/ATP 1.10 1.04 1.07 1.13 1.09 1.08 1.06
Grin2c
KLA  ATP  ATP+KLA
 NM_010350 glutamate receptor, ionotropic, NMDA2C (epsilon 3) (Grin2c), mRNA [NM_010350] KLA 1.09 1.13 1.19 1.24 1.14 1.15 1.09
ATP 1.05 .96 .98 .98 .94 1.01 1.10
KLA/ATP 1.08 1.14 1.09 1.05 1.05 .98 1.01
Grin2d
KLA  ATP  ATP+KLA
 NM_008172 glutamate receptor, ionotropic, NMDA2D (epsilon 4) (Grin2d), mRNA [NM_008172] KLA 1.57 1.18 1.35 1.45 1.25 1.49 .91
ATP .92 .99 1.45 1.66 1.54 2.02 1.15
KLA/ATP 1.23 1.38 2.08 2.28 1.92 2.53 1.92
Grin3a
KLA  ATP  ATP+KLA
 AK044171 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830097C19 product:similar to IONOTROPIC GLUTAMATE RECEPTOR NMDA subunit NR3A[Rattus norvegicus], full insert sequence. [AK044171] KLA 1.06 1.00 .93 .95 .97 .97 .99
ATP .96 .97 1.02 .94 1.03 1.02 1.03
KLA/ATP 1.05 .96 1.05 .98 .94 1.02 1.03
Grin3b
KLA  ATP  ATP+KLA
 NM_130455 glutamate receptor, ionotropic, NMDA3B (Grin3b), mRNA [NM_130455] KLA .90 .92 .88 .98 .91 .91 .69
ATP .96 .93 .94 .92 .93 .84 .68
KLA/ATP .92 .88 .88 .95 .96 .88 .68
H2afj
KLA  ATP  ATP+KLA
 NM_177688 H2A histone family, member J (H2afj), mRNA [NM_177688] KLA .51 .52 .62 .67 .65 .67 .58
ATP .94 .85 .94 .91 .80 .76 .56
KLA/ATP .51 .46 .59 .80 .90 .86 .77
H2afx
KLA  ATP  ATP+KLA
 NM_010436 H2A histone family, member X (H2afx), mRNA [NM_010436] KLA .25 .24 .21 .24 .22 .30 .32
ATP 1.08 1.16 1.97 3.00 2.74 1.21 .31
KLA/ATP .27 .27 .63 1.77 2.44 1.33 .35
H2afy
KLA  ATP  ATP+KLA
 NM_012015 H2A histone family, member Y (H2afy), mRNA [NM_012015] KLA 1.89 1.87 1.99 1.91 2.31 1.63 1.06
ATP 1.14 1.13 .62 .95 .66 .60 .92
KLA/ATP 1.94 2.10 1.34 2.00 1.20 1.02 .97
H2afy2
KLA  ATP  ATP+KLA
 NM_207000 H2A histone family, member Y2 (H2afy2), mRNA [NM_207000] KLA 1.00 1.02 .96 1.04 1.09 1.06 .96
ATP 1.08 1.02 .93 .95 1.02 .96 1.20
KLA/ATP 1.04 .98 .90 .99 1.05 1.10 1.11
H2afz
KLA  ATP  ATP+KLA
 AK044932 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130014G07 product:H2A histone family, member Z, full insert sequence [AK044932] KLA 1.00 1.01 .93 .97 .94 1.00 1.01
ATP 1.03 1.05 1.03 .98 .97 1.09 1.02
KLA/ATP .96 .98 .97 .97 .97 1.03 1.10
H2afz
KLA  ATP  ATP+KLA
 NM_016750 H2A histone family, member Z (H2afz), mRNA [NM_016750] KLA 1.10 1.20 1.23 1.25 .99 .68 .41
ATP 1.00 .98 1.27 1.50 1.65 1.55 .47
KLA/ATP 1.10 1.13 1.18 1.36 1.58 1.54 .58
H3f3a
KLA  ATP  ATP+KLA
 NM_008210 H3 histone, family 3A (H3f3a), mRNA [NM_008210] KLA 1.06 1.08 1.16 1.19 1.21 1.49 1.57
ATP .99 .99 1.28 1.21 1.52 1.81 .78
KLA/ATP .91 .92 1.42 1.41 1.97 2.07 1.27
H3f3b
KLA  ATP  ATP+KLA
 NM_008211 H3 histone, family 3B (H3f3b), mRNA [NM_008211] KLA 2.30 2.24 2.39 2.46 2.24 2.79 1.50
ATP .85 .87 2.00 2.47 1.89 1.71 .93
KLA/ATP 2.10 2.17 3.76 4.47 4.37 3.19 2.20
Hat1
KLA  ATP  ATP+KLA
 NM_026115 histone aminotransferase 1 (Hat1), mRNA [NM_026115] KLA 1.72 1.79 2.28 2.44 2.30 1.96 1.04
ATP .98 .95 1.21 1.33 1.12 .91 .65
KLA/ATP 1.65 1.80 2.88 2.61 2.88 2.33 1.08
Hdac1
KLA  ATP  ATP+KLA
 U80780 putative histone deacetylase (HD1) mRNA, partial cds [U80780] KLA 2.59 2.39 2.48 2.74 3.36 2.56 1.22
ATP 1.13 1.26 1.18 1.08 .85 1.29 1.15
KLA/ATP 2.15 2.27 2.64 2.57 1.78 1.89 2.31
Hdac10
KLA  ATP  ATP+KLA
 NM_199198 histone deacetylase 10 (Hdac10), mRNA [NM_199198] KLA .66 .66 .66 .69 .72 .73 .76
ATP 1.05 1.05 .88 .81 .59 .48 .69
KLA/ATP .75 .72 .69 .71 .55 .54 .60
Hdac11
KLA  ATP  ATP+KLA
 NM_144919 histone deacetylase 11 (Hdac11), mRNA [NM_144919] KLA .82 .83 .86 .82 .77 .79 .78
ATP 1.02 1.07 .99 .85 .77 .75 .69
KLA/ATP .79 .81 .85 .74 .72 .78 .67
Hdac2
KLA  ATP  ATP+KLA
 AK051753 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130072G11 product:histone deacetylase 2, full insert sequence [AK051753] KLA .97 .97 .90 .96 1.02 .93 .96
ATP 1.02 1.03 .98 .96 .96 .90 1.05
KLA/ATP 1.00 .96 .87 .99 .92 1.00 .95
Hdac2
KLA  ATP  ATP+KLA
 NM_008229 histone deacetylase 2 (Hdac2), mRNA [NM_008229] KLA 1.27 1.35 1.33 1.18 1.03 .75 1.10
ATP .95 1.05 .79 .96 .82 .85 .81
KLA/ATP 1.28 1.43 .93 1.10 .82 .73 .60
Hdac3
KLA  ATP  ATP+KLA
 NM_010411 histone deacetylase 3 (Hdac3), mRNA [NM_010411] KLA .99 1.02 1.00 .97 1.00 1.10 .95
ATP .98 1.07 1.11 1.17 1.04 1.07 1.00
KLA/ATP 1.01 1.05 .97 1.08 1.00 1.14 1.28
Hdac4
KLA  ATP  ATP+KLA
 NM_207225 histone deacetylase 4 (Hdac4), mRNA [NM_207225] KLA .57 .59 .47 .49 .48 .54 .71
ATP 1.00 1.01 .84 1.35 1.05 1.51 .65
KLA/ATP .56 .54 .51 .69 .67 1.29 1.02
Hdac5
KLA  ATP  ATP+KLA
 NM_001077696 histone deacetylase 5 (Hdac5), transcript variant 1, mRNA [NM_001077696] KLA .41 .37 .37 .42 .52 .82 .76
ATP .95 .91 1.11 1.19 .66 .77 1.09
KLA/ATP .40 .36 .43 .50 .68 1.09 1.42
Hdac6
KLA  ATP  ATP+KLA
 NM_010413 histone deacetylase 6 (Hdac6), mRNA [NM_010413] KLA .72 .73 .65 .57 .55 .53 .63
ATP .98 1.01 .84 .90 .80 .90 .70
KLA/ATP .77 .71 .54 .64 .56 .72 .66
Hdac7
KLA  ATP  ATP+KLA
 NM_019572 histone deacetylase 7 (Hdac7), mRNA [NM_019572] KLA .64 .62 .61 .82 1.37 1.41 1.35
ATP 1.01 1.07 1.00 1.05 .74 1.00 1.40
KLA/ATP .66 .67 .68 .73 .74 .73 1.83
Hdac8
KLA  ATP  ATP+KLA
 NM_027382 histone deacetylase 8 (Hdac8), mRNA [NM_027382] KLA .93 1.03 .92 .99 .94 1.01 1.00
ATP .91 1.01 .97 .98 .77 .85 .86
KLA/ATP .94 1.02 .96 .99 .91 .85 .82
Hdac9
KLA  ATP  ATP+KLA
 NM_024124 histone deacetylase 9 (Hdac9), mRNA [NM_024124] KLA .77 .78 .74 .84 1.15 .96 .93
ATP .89 1.02 1.20 1.00 .60 .57 .69
KLA/ATP .69 .87 .88 .77 .73 .50 .81
Hist1h2a
a
KLA  ATP  ATP+KLA
 NM_175658 histone cluster 1, H2aa (Hist1h2aa), mRNA [NM_175658] KLA .38 .41 .42 .42 .37 .44 .30
ATP .98 .97 1.27 1.05 .64 .64 .50
KLA/ATP .39 .38 .55 .57 .50 .58 .75
Hist1h2a
b
KLA  ATP  ATP+KLA
 NM_175660 histone cluster 1, H2ab (Hist1h2ab), mRNA [NM_175660] KLA .47 .46 .43 .42 .33 .38 .27
ATP .88 1.02 1.85 1.55 .78 .46 .32
KLA/ATP .41 .50 .65 .64 .49 .40 .38
Hist1h2a
c
KLA  ATP  ATP+KLA
 NM_178189 histone cluster 1, H2ac (Hist1h2ac), mRNA [NM_178189] KLA 1.01 .92 .99 .98 .95 1.00 1.08
ATP .97 1.04 1.41 2.00 1.18 1.04 .95
KLA/ATP .93 .97 1.06 1.37 1.06 1.00 1.08
Hist1h2a
e
KLA  ATP  ATP+KLA
 NM_178187 histone cluster 1, H2ae (Hist1h2ae), mRNA [NM_178187] KLA .96 1.05 1.02 .99 .92 .94 .88
ATP 1.02 1.19 2.03 2.39 1.94 1.77 1.40
KLA/ATP .91 1.09 1.22 1.32 1.34 1.08 .91
Hist1h2a
f
KLA  ATP  ATP+KLA
 NM_175661 histone cluster 1, H2af (Hist1h2af), mRNA [NM_175661] KLA .34 .36 .33 .32 .27 .32 .19
ATP .94 1.02 1.45 1.09 .66 .52 .32
KLA/ATP .33 .32 .51 .50 .38 .42 .47
Hist1h2a
i
KLA  ATP  ATP+KLA
 NM_178182 histone cluster 1, H2ai (Hist1h2ai), mRNA [NM_178182] KLA .44 .43 .43 .40 .33 .38 .22
ATP .84 .90 1.57 1.33 .75 .62 .30
KLA/ATP .38 .41 .70 .67 .55 .54 .41
Hist1h2a
k
KLA  ATP  ATP+KLA
 NM_178183 histone cluster 1, H2ak (Hist1h2ak), mRNA [NM_178183] KLA .34 .38 .37 .30 .25 .28 .16
ATP .87 .93 1.55 1.24 .68 .52 .25
KLA/ATP .34 .33 .52 .56 .42 .41 .35
Hist1h2b
a
KLA  ATP  ATP+KLA
 NM_175663 histone cluster 1, H2ba (Hist1h2ba), mRNA [NM_175663] KLA 1.02 .98 .79 .95 .80 1.30 2.48
ATP 1.08 .95 1.96 3.71 4.00 4.55 2.49
KLA/ATP .97 .88 1.87 2.92 3.78 3.95 3.51
Hist1h2b
c
KLA  ATP  ATP+KLA
 NM_023422 histone cluster 1, H2bc (Hist1h2bc), mRNA [NM_023422] KLA .91 .87 .80 .86 .74 1.35 2.94
ATP 1.00 .83 1.89 4.30 4.12 4.38 2.35
KLA/ATP 1.07 .82 1.29 2.92 3.55 4.37 4.26
Hist1h2b
e
KLA  ATP  ATP+KLA
 NM_178194 histone cluster 1, H2be (Hist1h2be), mRNA [NM_178194] KLA .91 1.00 1.00 1.01 .91 1.06 1.13
ATP 1.02 1.07 1.09 1.04 .99 1.02 1.00
KLA/ATP 1.06 1.01 1.06 1.09 1.04 1.03 1.06
Hist1h2b
k
KLA  ATP  ATP+KLA
 NM_175665 histone cluster 1, H2bk (Hist1h2bk), mRNA [NM_175665] KLA .88 .91 .82 .88 .75 1.25 2.49
ATP .97 .83 2.07 3.65 3.58 3.77 2.19
KLA/ATP .94 .81 1.52 2.51 3.36 3.76 3.20
Hist1h2b
m
KLA  ATP  ATP+KLA
 NM_178200 histone cluster 1, H2bm (Hist1h2bm), mRNA [NM_178200] KLA .88 .90 .80 .81 .68 1.18 2.48
ATP .94 .86 2.00 3.59 3.39 3.57 2.23
KLA/ATP .91 .80 1.42 2.43 3.16 3.54 3.19
Hist1h2b
p
KLA  ATP  ATP+KLA
 AK076671 adult male testis cDNA, RIKEN full-length enriched library, clone:4930408P03 product:HISTONE H2B (FRAGMENT) homolog [Mus musculus], full insert sequence. [AK076671] KLA .84 .87 .93 .94 .85 .92 1.04
ATP .97 .91 1.23 1.40 1.02 .80 .91
KLA/ATP .87 .82 .88 .95 .92 .87 .88
Hist1h3a
KLA  ATP  ATP+KLA
 NM_013550 histone cluster 1, H3a (Hist1h3a), mRNA [NM_013550] KLA .86 .91 1.03 1.06 .96 .97 .95
ATP .97 1.14 2.05 3.06 2.48 2.55 1.19
KLA/ATP .92 1.04 1.38 1.85 1.82 1.79 1.27
Hist1h3d
KLA  ATP  ATP+KLA
 NM_178204 histone cluster 1, H3d (Hist1h3d), mRNA [NM_178204] KLA 2.02 2.07 2.29 2.29 2.12 2.54 1.63
ATP 1.00 .98 1.54 2.39 2.20 2.14 1.36
KLA/ATP 2.02 2.20 3.05 4.09 4.58 3.59 3.12
Hist1h4a
KLA  ATP  ATP+KLA
 NM_178192 histone cluster 1, H4a (Hist1h4a), mRNA [NM_178192] KLA .83 .88 .73 .73 .54 .67 .40
ATP .78 .91 2.28 2.85 1.76 1.53 .74
KLA/ATP .66 .73 1.64 1.84 1.35 1.15 .74
Hist1h4d
KLA  ATP  ATP+KLA
 NM_175654 histone cluster 1, H4d (Hist1h4d), mRNA [NM_175654] KLA .77 .78 .64 .59 .42 .53 .29
ATP .83 .90 1.97 2.16 1.33 1.09 .55
KLA/ATP .61 .63 1.19 1.24 .78 .67 .49
Hist1h4f
KLA  ATP  ATP+KLA
 NM_175655 histone cluster 1, H4f (Hist1h4f), mRNA [NM_175655] KLA .67 .71 .59 .53 .38 .48 .29
ATP .79 .86 1.99 2.30 1.46 1.29 .66
KLA/ATP .55 .56 1.07 1.17 .84 .86 .63
Hist1h4i
KLA  ATP  ATP+KLA
 BF467941 gb|UI-M-CC0-ayb-f-07-0-UI.r1 NIH_BMAP_Ret1 Mus musculus cDNA clone UI-M-CC0-ayb-f-07-0-UI 5. [BF467941] KLA 1.10 1.11 1.14 1.22 .92 1.30 1.57
ATP .67 .79 4.06 5.43 4.86 5.73 3.17
KLA/ATP .99 1.23 3.46 3.53 4.21 3.78 5.09
Hist2h2a
a1
KLA  ATP  ATP+KLA
 AK028129 adult male stomach cDNA, RIKEN full-length enriched library, clone:2210403F13 product:histone gene complex 2, full insert sequence [AK028129] KLA .73 .78 .80 .68 .81 .91 .97
ATP .99 1.00 .90 .80 .62 .67 .90
KLA/ATP .78 .76 .70 .64 .72 .65 .77
Hist2h2a
a1
KLA  ATP  ATP+KLA
 NM_013549 histone cluster 2, H2aa1 (Hist2h2aa1), mRNA [NM_013549] KLA .93 1.09 1.23 1.22 1.12 1.24 1.42
ATP .97 1.03 1.48 1.83 1.59 1.99 2.88
KLA/ATP .96 1.14 1.56 1.84 1.67 2.45 6.50
Hist2h2a
c
KLA  ATP  ATP+KLA
 NM_175662 histone cluster 2, H2ac (Hist2h2ac), mRNA [NM_175662] KLA .43 .46 .46 .43 .40 .45 .32
ATP .95 1.02 1.18 1.11 .71 .70 .54
KLA/ATP .41 .41 .56 .61 .55 .64 .83
Hist2h2b
b
KLA  ATP  ATP+KLA
 BC019122 histone cluster 2, H2bb, mRNA (cDNA clone MGC:29103 IMAGE:5003093), complete cds [BC019122] KLA .98 1.08 1.07 1.07 1.10 1.16 1.08
ATP .89 .87 1.96 5.64 2.29 1.19 1.03
KLA/ATP 1.02 .98 1.69 5.25 2.33 1.47 1.29
Hist2h2b
e
KLA  ATP  ATP+KLA
 NM_178214 histone cluster 2, H2be (Hist2h2be), mRNA [NM_178214] KLA .94 .96 .86 .71 .69 1.19 .98
ATP .76 .68 1.00 .72 .61 .83 1.16
KLA/ATP 1.22 1.01 2.41 3.18 3.20 2.00 1.97
Hist2h3c
1
KLA  ATP  ATP+KLA
 NM_178216 histone cluster 2, H3c1 (Hist2h3c1), transcript variant 2, mRNA [NM_178216] KLA 1.98 2.04 2.22 2.28 2.10 2.55 1.66
ATP .95 .90 1.44 2.09 1.84 2.00 1.40
KLA/ATP 1.94 1.90 3.07 3.84 4.33 3.44 3.00
Hist2h4
KLA  ATP  ATP+KLA
 NM_033596 histone cluster 2, H4 (Hist2h4), mRNA [NM_033596] KLA .77 .79 .68 .60 .41 .51 .29
ATP .83 .93 2.16 2.49 1.59 1.44 .65
KLA/ATP .64 .64 1.32 1.39 1.00 .92 .63
Hist3h2a
KLA  ATP  ATP+KLA
 NM_178218 histone cluster 3, H2a (Hist3h2a), mRNA [NM_178218] KLA .78 .80 .81 .93 .83 .91 .54
ATP 1.03 1.05 1.42 1.32 1.06 1.04 .67
KLA/ATP .72 .80 1.31 1.31 1.26 1.48 1.41
Hist3h2b
a
KLA  ATP  ATP+KLA
 NM_030082 histone cluster 3, H2ba (Hist3h2ba), mRNA [NM_030082] KLA .84 .93 .98 .92 .87 1.37 1.55
ATP .91 .91 1.41 1.22 .93 .84 .85
KLA/ATP .80 .83 1.14 1.11 .97 2.07 7.01
Hist3h2b
b
KLA  ATP  ATP+KLA
 NM_206882 histone cluster 3, H2bb (Hist3h2bb), mRNA [NM_206882] KLA 1.01 .93 .83 .90 .79 1.25 2.56
ATP 1.10 .97 2.03 3.38 3.78 3.89 2.43
KLA/ATP 1.04 .89 1.63 2.55 3.35 3.88 3.43
Hist4h4
KLA  ATP  ATP+KLA
 AK045187 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130044J01 product:H4 HISTONE homolog [Homo sapiens], full insert sequence [AK045187] KLA .96 .90 1.02 1.03 .97 1.01 1.03
ATP 1.01 1.07 .97 .99 .95 1.01 1.00
KLA/ATP 1.00 1.13 .97 1.04 1.03 1.00 .98
Hist4h4
KLA  ATP  ATP+KLA
 NM_175652 histone cluster 4, H4 (Hist4h4), mRNA [NM_175652] KLA .81 .87 .69 .76 .54 .67 .40
ATP .84 .92 2.25 2.71 1.64 1.51 .72
KLA/ATP .69 .75 1.53 1.74 1.28 1.08 .80
Hras1
KLA  ATP  ATP+KLA
 NM_008284 Harvey rat sarcoma virus oncogene 1 (Hras1), mRNA [NM_008284] KLA .79 .82 .77 .82 .94 1.03 1.07
ATP 1.01 .95 .69 .83 .79 1.12 1.15
KLA/ATP .84 .77 .61 .65 .82 1.00 1.05
Kras
KLA  ATP  ATP+KLA
 NM_021284 v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (Kras), mRNA [NM_021284] KLA .53 .49 .40 .42 .49 .95 1.05
ATP .98 1.01 1.16 1.17 1.39 1.29 1.74
KLA/ATP .50 .47 .50 .56 1.00 1.24 1.58
Maoa
KLA  ATP  ATP+KLA
 NM_173740 monoamine oxidase A (Maoa), nuclear gene encoding mitochondrial protein, mRNA [NM_173740] KLA 1.14 1.11 1.06 1.07 .84 .55 .53
ATP 1.10 1.07 1.33 1.20 1.44 2.37 1.38
KLA/ATP .97 1.11 1.75 1.33 1.27 1.21 1.09
Maob
KLA  ATP  ATP+KLA
 NM_172778 monoamine oxidase B (Maob), nuclear gene encoding mitochondrial protein, mRNA [NM_172778] KLA 1.01 .97 1.01 1.05 1.01 .95 1.01
ATP 1.09 .98 .99 .97 1.03 1.03 .94
KLA/ATP 1.02 1.05 .99 1.02 1.00 .98 .98
Map2k1
KLA  ATP  ATP+KLA
 NM_008927 mitogen-activated protein kinase kinase 1 (Map2k1), mRNA [NM_008927] KLA 1.82 2.00 2.31 2.03 2.51 2.20 1.51
ATP .99 1.14 .81 .87 .90 1.57 1.11
KLA/ATP 1.90 2.03 1.50 1.93 1.63 2.03 2.06
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mm.21254
9
KLA  ATP  ATP+KLA
 142376228 Unknown KLA 2.23 2.18 2.36 2.57 2.10 2.61 1.52
ATP .80 .75 1.25 1.46 .96 1.40 1.18
KLA/ATP 1.46 1.62 2.46 2.73 1.74 2.50 3.29
Mm.22094
6
KLA  ATP  ATP+KLA
 27545180 Unknown KLA 1.00 .93 .97 1.05 1.06 1.29 1.13
ATP .90 .94 1.25 1.18 .85 .62 1.20
KLA/ATP .86 .99 1.14 .99 .83 .70 1.26
Mm.22665
KLA  ATP  ATP+KLA
 118136294 Unknown KLA .27 .24 .24 .28 .40 .65 .62
ATP .91 .87 1.07 1.07 .55 .70 1.09
KLA/ATP .26 .24 .27 .33 .54 1.02 1.43
Mm.24833
5
KLA  ATP  ATP+KLA
 110350004 Unknown KLA .83 .79 .63 .93 .75 1.10 1.03
ATP 10.10 12.76 17.13 18.61 13.01 3.37 1.36
KLA/ATP 3.05 5.96 4.94 8.73 5.80 4.08 1.91
Mm.26167
0
KLA  ATP  ATP+KLA
 20799906 Unknown KLA 1.01 1.04 .98 1.06 .90 1.23 2.47
ATP .85 .93 1.41 1.52 1.34 2.12 5.55
KLA/ATP .96 1.01 1.34 1.73 1.67 2.60 10.21
Mm.27568
1
KLA  ATP  ATP+KLA
 77539461 Unknown KLA .93 .88 .93 .99 .92 .96 .92
ATP 1.05 1.03 1.05 .91 .97 1.02 .88
KLA/ATP .96 .93 .94 .90 .88 .84 .91
Mm.32259
4
KLA  ATP  ATP+KLA
 144922605 Unknown KLA 1.02 1.03 .98 .98 .95 1.00 1.02
ATP 1.01 .98 1.08 1.01 1.04 1.01 .97
KLA/ATP .97 1.08 1.04 1.02 1.00 1.01 1.03
Mm.35895
4
KLA  ATP  ATP+KLA
 30089709 Unknown KLA .40 .41 .42 .41 .37 .44 .28
ATP .87 .95 1.25 1.06 .68 .67 .49
KLA/ATP .36 .38 .55 .57 .52 .61 .73
Mm.35895
5
KLA  ATP  ATP+KLA
 30089703 Unknown KLA .90 .90 .87 .84 .75 1.22 2.50
ATP 1.06 .91 2.11 3.91 3.77 4.01 2.40
KLA/ATP 1.03 .86 1.54 2.57 3.56 3.79 3.54
Mm.37176
6
KLA  ATP  ATP+KLA
 160420311 Unknown KLA .49 .34 .80 .82 .87 1.14 1.04
ATP .43 .30 1.42 1.53 .98 3.32 1.63
KLA/ATP .38 .20 .99 1.14 1.03 2.63 1.63
Mm.37789
8
KLA  ATP  ATP+KLA
 46049028 Unknown KLA 1.08 1.00 1.07 1.02 1.10 .95 .96
ATP .98 .98 1.01 1.01 .89 1.07 1.05
KLA/ATP .95 1.00 1.13 1.00 .97 .99 1.03
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.42268
0
KLA  ATP  ATP+KLA
 9506766 Unknown KLA 2.08 2.13 2.15 2.32 2.08 2.61 1.60
ATP .92 .92 1.55 2.40 2.08 2.17 1.45
KLA/ATP 1.95 2.02 3.30 4.29 4.84 3.79 3.35
Mm.44009
5
KLA  ATP  ATP+KLA
 166158133 Unknown KLA .99 1.03 1.07 1.00 1.07 1.07 1.06
ATP .98 1.01 .98 .94 1.06 .96 .95
KLA/ATP 1.04 1.05 1.00 .97 1.06 .99 .95
Mm.44050
5
KLA  ATP  ATP+KLA
 84579905 Unknown KLA 1.03 .96 .90 1.03 .94 1.15 1.23
ATP .88 .91 1.15 1.18 1.17 1.31 1.02
KLA/ATP .87 .97 1.19 1.18 1.36 1.34 1.25
Mm.44230
7
KLA  ATP  ATP+KLA
 30061354 Unknown KLA .68 .77 .60 .53 .36 .48 .29
ATP .76 .92 2.12 2.50 1.62 1.40 .68
KLA/ATP .59 .60 1.18 1.38 .95 .89 .66
Mm.45107
1
KLA  ATP  ATP+KLA
 68226432 Unknown KLA .96 1.04 .99 1.06 .87 1.37 2.42
ATP .96 .86 2.23 3.91 3.43 3.57 2.09
KLA/ATP 1.01 .96 1.81 2.89 3.45 3.52 2.98
Mm.47367
1
KLA  ATP  ATP+KLA
 149270962 Unknown KLA .99 .98 .94 .95 .84 .91 .93
ATP 1.04 1.00 1.07 .96 .85 .94 .98
KLA/ATP 1.01 .88 .89 .90 .94 .92 .78
Mm.54161
KLA  ATP  ATP+KLA
 164607143 Unknown KLA .97 .99 1.00 .98 .95 .98 .94
ATP 1.01 .99 1.06 1.07 1.02 .95 .98
KLA/ATP .93 1.04 1.07 .96 .90 .95 .94
Npy
KLA  ATP  ATP+KLA
 NM_023456 neuropeptide Y (Npy), mRNA [NM_023456] KLA 1.20 1.09 1.29 1.31 1.37 1.42 1.83
ATP 1.18 1.35 1.22 2.59 2.67 2.65 6.39
KLA/ATP 1.37 1.50 1.23 2.29 2.12 2.71 6.93
Nras
KLA  ATP  ATP+KLA
 NM_010937 neuroblastoma ras oncogene (Nras), mRNA [NM_010937] KLA 1.20 1.22 1.27 1.20 1.09 .91 .84
ATP .98 .91 .69 .61 .59 .67 .78
KLA/ATP 1.22 1.14 .97 .79 .73 .61 .72
Ntrk2
KLA  ATP  ATP+KLA
 AK018789 adult male cerebellum cDNA, RIKEN full-length enriched library, clone:1500040I13 product:neurotrophic tyrosine kinase, receptor, type 2, full insert sequence. [AK018789] KLA 1.02 .94 1.05 1.03 1.03 1.03 1.04
ATP .99 1.01 1.09 .95 1.02 .99 1.04
KLA/ATP 1.02 .96 1.00 1.04 1.13 .99 1.03
Ntrk2
KLA  ATP  ATP+KLA
 NM_001025074 neurotrophic tyrosine kinase, receptor, type 2 (Ntrk2), transcript variant 1, mRNA [NM_001025074] KLA .99 .99 1.02 1.02 1.02 1.00 1.03
ATP .99 .99 .99 .99 1.00 1.01 1.03
KLA/ATP .97 1.00 1.01 1.00 .99 .98 1.00
Ntrk2
KLA  ATP  ATP+KLA
 NM_008745 neurotrophic tyrosine kinase, receptor, type 2 (Ntrk2), transcript variant 2, mRNA [NM_008745] KLA .99 1.00 .99 1.00 .99 1.00 1.02
ATP 1.01 1.00 1.01 .97 1.01 1.01 .99
KLA/ATP .99 1.01 .99 1.01 .99 .99 1.01
Pkia
KLA  ATP  ATP+KLA
 M63554 inhibitor protein of cAMP-dependent protein kinase, complete cds. [M63554] KLA .98 1.06 1.04 .92 1.04 .95 .98
ATP 1.00 1.01 1.07 .98 .98 1.01 1.11
KLA/ATP .97 .90 1.11 1.01 1.02 1.02 1.05
Pkia
KLA  ATP  ATP+KLA
 NM_008862 protein kinase inhibitor, alpha (Pkia), mRNA [NM_008862] KLA .94 .98 .92 1.02 .97 .96 1.04
ATP 1.00 .99 1.02 .98 .96 .95 .93
KLA/ATP .89 1.02 .96 .99 .98 .98 1.08
Ppp1ca
KLA  ATP  ATP+KLA
 NM_031868 protein phosphatase 1, catalytic subunit, alpha isoform (Ppp1ca), mRNA [NM_031868] KLA .89 .93 .93 .86 .95 1.07 1.20
ATP 1.04 1.07 .93 1.02 1.01 .89 1.10
KLA/ATP .98 .93 .74 .91 .84 1.01 1.34
Ppp1cb
KLA  ATP  ATP+KLA
 NM_172707 protein phosphatase 1, catalytic subunit, beta isoform (Ppp1cb), mRNA [NM_172707] KLA 1.12 1.08 1.05 1.02 .89 .84 .94
ATP .89 .87 .75 .55 .73 1.14 .69
KLA/ATP .92 .94 .80 .64 .64 .83 .65
Ppp1cc
KLA  ATP  ATP+KLA
 NM_013636 protein phosphatase 1, catalytic subunit, gamma isoform (Ppp1cc), mRNA [NM_013636] KLA .51 .51 .49 .48 .53 .64 .64
ATP 1.02 1.01 .85 .79 .72 .89 .95
KLA/ATP .54 .49 .42 .43 .56 .76 .81
Ppp1r1b
KLA  ATP  ATP+KLA
 NM_144828 protein phosphatase 1, regulatory (inhibitor) subunit 1B (Ppp1r1b), mRNA [NM_144828] KLA 1.20 1.17 1.12 1.24 1.22 1.18 1.06
ATP .97 1.09 1.06 1.13 1.04 1.17 1.12
KLA/ATP 1.09 1.10 1.27 1.28 1.10 1.12 1.12
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Raf1
KLA  ATP  ATP+KLA
 AK036317 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630056E02 product:v-raf-1 leukemia viral oncogene 1, full insert sequence. [AK036317] KLA 1.47 1.34 1.55 1.29 1.59 1.32 1.46
ATP 1.05 .98 .54 .63 3.32 2.07 1.01
KLA/ATP 1.57 1.33 .79 .96 2.26 1.38 1.35
Raf1
KLA  ATP  ATP+KLA
 NM_029780 v-raf-leukemia viral oncogene 1 (Raf1), mRNA [NM_029780] KLA 1.65 1.64 1.93 1.77 1.77 1.72 1.81
ATP .95 .96 .83 .80 2.22 2.92 1.19
KLA/ATP 1.68 1.64 1.39 1.32 1.85 2.50 2.06
RP23-38E
20.1
KLA  ATP  ATP+KLA
 NM_001097979 H2b histone family, member A (LOC665596), mRNA [NM_001097979] KLA .72 .54 .87 .92 .94 1.01 1.10
ATP .67 .52 1.08 1.27 .94 1.78 1.24
KLA/ATP .69 .38 .87 1.15 .98 1.46 1.21
Shc1
KLA  ATP  ATP+KLA
 NM_011368 src homology 2 domain-containing transforming protein C1 (Shc1), transcript variant 2, mRNA [NM_011368] KLA .88 .87 .86 .83 1.09 1.11 1.12
ATP 1.04 1.25 .85 1.17 .93 1.16 1.00
KLA/ATP .93 .96 .62 .96 .75 1.25 1.19
Shc2
KLA  ATP  ATP+KLA
 NM_001024539 src homology 2 domain-containing transforming protein C2 (Shc2), mRNA [NM_001024539] KLA 1.19 1.25 1.22 1.16 1.15 1.14 .98
ATP 1.04 1.14 1.15 1.53 1.29 1.06 1.09
KLA/ATP 1.26 1.24 1.26 1.49 1.31 1.30 1.30
Shc3
KLA  ATP  ATP+KLA
 NM_009167 src homology 2 domain-containing transforming protein C3 (Shc3), mRNA [NM_009167] KLA 1.00 .98 1.06 1.06 1.12 1.08 1.04
ATP .99 1.02 1.00 1.05 1.00 1.08 1.08
KLA/ATP 1.08 1.06 1.01 1.06 1.03 1.12 1.41
Shc4
KLA  ATP  ATP+KLA
 NM_199022 SHC (Src homology 2 domain containing) family, member 4 (Shc4), mRNA [NM_199022] KLA 1.03 1.03 1.01 1.06 1.09 1.03 1.06
ATP .99 1.00 1.03 1.02 1.04 1.04 1.01
KLA/ATP .98 .97 1.06 1.05 1.00 1.00 1.14
Slc18a1
KLA  ATP  ATP+KLA
 AK049514 7 days embryo whole body cDNA, RIKEN full-length enriched library, clone:C430018J19 product:CHROMAFFIN GRANULE AMINE TRANSPORTER (VESICULAR AMINE TRANSPORTER 1) (VAT1) homolog [Rattus norvegicus], full insert sequence. [AK049514] KLA 1.08 1.09 1.04 1.02 1.06 1.01 .99
ATP .98 .94 .98 .98 1.08 .98 1.03
KLA/ATP 1.01 .97 .94 1.06 1.03 1.01 1.24
Slc18a1
KLA  ATP  ATP+KLA
 NM_153054 solute carrier family 18 (vesicular monoamine), member 1 (Slc18a1), mRNA [NM_153054] KLA 1.13 1.10 1.33 1.27 1.37 1.41 1.56
ATP .86 .78 .83 .61 .70 .45 1.22
KLA/ATP .96 1.02 .92 .73 .94 .90 4.36
Slc18a2
KLA  ATP  ATP+KLA
 NM_172523 solute carrier family 18 (vesicular monoamine), member 2 (Slc18a2), mRNA [NM_172523] KLA .98 .97 .95 .94 .94 .99 .92
ATP .98 1.01 .96 .95 .96 .96 .98
KLA/ATP .91 .94 .91 .92 .96 .95 .93
Slc29a1
KLA  ATP  ATP+KLA
 NM_022880 solute carrier family 29 (nucleoside transporters), member 1 (Slc29a1), nuclear gene encoding mitochondrial protein, mRNA [NM_022880] KLA .95 .97 1.01 .85 .83 .51 .57
ATP 1.12 1.26 1.24 1.57 1.19 .57 .37
KLA/ATP 1.08 1.16 1.01 1.33 .87 .79 .46
Slc6a3
KLA  ATP  ATP+KLA
 NM_010020 solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 (Slc6a3), mRNA [NM_010020] KLA 1.03 .97 1.04 1.02 1.02 1.01 .98
ATP 1.02 .98 .91 1.00 .98 1.00 .98
KLA/ATP .97 .90 1.02 1.03 1.01 .90 .99
Sos1
KLA  ATP  ATP+KLA
 NM_009231 Son of sevenless homolog 1 (Drosophila) (Sos1), mRNA [NM_009231] KLA 2.36 2.40 3.42 3.15 2.78 1.81 1.71
ATP .99 1.00 .99 1.15 1.14 1.25 1.24
KLA/ATP 2.41 2.26 1.95 2.44 1.47 1.66 1.37
Sos2
KLA  ATP  ATP+KLA
 XM_127051 gb|PREDICTED: Mus musculus Son of sevenless homolog 2 (Drosophila) (Sos2), mRNA [XM_127051] KLA .81 .77 .79 .92 1.04 1.06 1.20
ATP 1.00 1.00 1.09 .79 .68 .81 .94
KLA/ATP .77 .69 .71 .60 .64 .77 1.07
Th
KLA  ATP  ATP+KLA
 NM_009377 tyrosine hydroxylase (Th), mRNA [NM_009377] KLA 1.00 1.01 1.00 1.00 1.00 1.00 1.00
ATP .98 1.01 1.00 1.00 1.00 .99 1.01
KLA/ATP 1.00 1.01 1.01 1.00 1.01 .98 1.02